[ET Net News Agency, 15 March 2021] CSPC Pharmaceutical Group Limited (01093) said for
the year ended 31 December 2020, profit attributable to shareholders increased by 38.9% to
RMB5,160 million. Basic earnings per share were RMB43.16 cents. The board recommends a
final dividend of HK9 cents per share.
The group's revenue increased by 12.8% to RMB24,942 million. (RC)